Page 111 - 《中国药房》2025年1期
P. 111

·药师与药学服务·


          注射用亚胺培南西司他丁钠用于儿童的分剂量及稳定性研究
                                                                                                       Δ

                *
                                        #
          张先明 ,朱增燕,王文静,杜小换(苏州大学附属儿童医院药剂科,江苏 苏州 215000)
          中图分类号  R978.1;R917      文献标志码  A      文章编号  1001-0408(2025)01-0101-05
          DOI  10.6039/j.issn.1001-0408.2025.01.17
          摘  要  目的  考察注射用亚胺培南西司他丁钠(ICS)的分剂量对其主药亚胺培南(IPN)含量一致性的影响以及不同浓度药液的
          稳定性,为儿童安全、有效使用ICS提供参考。方法  3名操作员按照临床儿童常用的2种分剂量方式(以10 mL或20 mL的0.9%
          氯化钠注射液制成ICS初溶药液,自初溶药液中吸取所需药量)制备ICS供试液,平行处理后通过超高效液相色谱-串联质谱联用
          法测定IPN的含量,根据IPN含量变异系数(CV)<15%判断每组供试液的含量一致性。按照说明书配制ICS供试液X1,再将X1以
          0.9%氯化钠注射液按1∶1和1∶2体积比稀释后制得供试液X2和X3,分别置于室温[(23.0±0.5)℃]、30 ℃恒温水浴锅以及2~8 ℃
          冰箱内保存,以规定放置温度和时间下测得的IPN质量浓度与初始(0 h)质量浓度之比判断药液稳定性(比值≥90%则认为药液稳
          定)。结果  每位操作员以2种分剂量方式制得的每组药液中,IPN含量的CV均小于15%,表明IPN的含量偏差较小。3个质量浓
          度水平的药液在室温6 h或冷藏18 h条件下均较稳定;在30 ℃放置6 h时,供试液X1和X2也可保持稳定,但供试液X3中IPN的质
          量浓度较0 h时的质量浓度下降约20%。结论  ICS在儿童常用的2种分剂量方式下,其主药IPN的含量一致性较好。ICS药液的
          稳定性受浓度、温度和时间的影响,更低的浓度在更高的温度下会导致IPN的稳定性降低。临床应注意控制医嘱溶媒量以及配制
          和使用过程中的环境温度与时间。
          关键词  注射用亚胺培南西司他丁钠;亚胺培南;分剂量;儿童;稳定性

          Study on manipulation and stability of Imipenem and cilastatin sodium for injection in children
          ZHANG Xianming,ZHU Zengyan,WANG Wenjing,DU Xiaohuan(Dept.  of  Pharmacy,  Children’s  Hospital  of
          Soochow University, Jiangsu Suzhou 215000, China)

          ABSTRACT   OBJECTIVE  To  evaluate  the  effect  of  manipulation  of  Imipenem  and  cisplatin  sodium (ICS)  for  injection  on  the
          consistency  of  its  main  drug  imipenem (IPN)  content,  and  the  stability  of  different  concentrations  of  ICS  solution,  to  provide  a
          reference for the safe and effective use of ICS in children. METHODS Three operators prepared ICS solutions according to the two
          commonly  used  dosage  methods  for  children (10  mL  or  20  mL  0.9%  Sodium  chloride  injection  to  prepare  the  initial  ICS  solution
          and  draw  the  required  dose  from  the  initial  suspension).  The  content  of  IPN  was  determined  by  ultra-high  performance  liquid
          chromatography-tandem  mass  spectrometry  after  parallel  processing.  The  content  consistency  of  solutions  in  each  group  was
          determined according to the coefficient of variation (CV)<15% of the IPN content. ICS test solution X1 was prepared according to
          the instructions, and then test solutions X2 and X3 were prepared by diluting X1 with 0.9% Sodium chloride injection in the volume
          ratios of  1∶1  and  1∶2,  which  were  stored  at room  temperature  [(23.0±0.5)  ℃],  in  a  thermostatic  water bath at 30  ℃,  and  in  a
          refrigerator at 2-8 ℃. The stability of the drug solution was determined by the ratio of the IPN mass concentration measured at the
          specified  temperature  and  time  to  the  initial (0  h)  mass  concentration (if  the  ratio  was≥90%,  it  was  considered  that  the  drug
          solution was stable). RESULTS CV of IPN content was <15% in each group of solutions prepared with two manipulation methods
          by  each  operator,  indicating  a  small  deviation  in  IPN  content.  The  solutions  at  the  three  concentration  levels  were  stable  at  room
          temperature for 6 h or refrigerated for 18 h. The test solutions X1 and X2 were also stable when placed at 30 ℃ for 6 h, but the IPN
          concentration  in  test  solution  X3  decreased  by  about  20%  compared  with  that  of  0  h.  CONCLUSIONS  The  consistency  of  the
          content  of  IPN  is  good  in  the  two  commonly  used  methods  for  ICS  manipulation  in  children.  The  stability  of  ICS  solution  is
          affected by concentration, temperature and time. Lower concentrations at higher temperatures resulted in decreased stability of IPN.
          Clinical attention should be paid to controlling the amount of solvent as well as temperature and time during preparation and use.
          KEYWORDS    Imipenem and cisplatin sodium for injection; imipenem; manipulation; children; stability


             Δ 基金项目 江苏省药学会-恒瑞医院药学基金立项课题(No.
                                                                 儿童适宜药品缺乏是全球普遍情况,儿童在使用成
          H202342)                                           人剂型和规格的药品时,需要进行分剂量操作                     [1―2] 。但
             * 第一作者 副 主 任 药 师 。 研 究 方 向 :医 院 药 学 。 E-mail:
                                                             如果分剂量操作不规范,就会产生剂量不准确、交叉污
          395607153@qq.com                                           [3―5]
             # 通信作者 副主任药师,硕士。研究方向:治疗药物监测与儿童                  染等风险       。已有学者对口服剂型的分剂量方式、药
                                                                                    [6]
                                                                                                      [7]
          个体化用药。E-mail:dxhszet@163.com                       物稳定性等方面开展研究 ,并制定了团体标准 ,但注
          中国药房  2025年第36卷第1期                                                 China Pharmacy  2025 Vol. 36  No. 1    · 101 ·
   106   107   108   109   110   111   112   113   114   115   116